JAMA Health Forum Conversations

The COVID-19 pandemic has created an unprecedented need for accelerated collaborative research in health care systems. In a conversation with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Jonathan Perlin, MD, PhD, of the Joint Commission (and formerly of HCA Healthcare) discusses lessons learned from a novel COVID-19 research consortium developed through a...

The health care workforce has yet to recover from the COVID-19 pandemic, and there is a concerning trend of increasing numbers of physicians leaving the workforce. JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, discuss with Bianca Frogner, PhD, of the University of Washington new findings that show how all segments of the health care workforce have struggled...

Prison staff and residents have faced increased risks of COVID-19 infections. JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Jeremy Goldhaber-Fiebert, PhD of Stanford University about patterns of COVID-19 vaccinations among staff in California state prisons. They also speak with Jaimie Meyer, MD, MS of Yale University about efforts to promote COVI...

For the duration of the COVID-19 pandemic public health emergency, state Medicaid programs elected to maintain eligibility for Medicaid recipients in exchange for increased federal funding. In this podcast, Dr Laura Dague of the Bush School of Government & Public Service at Texas A&M University discusses her JAMA Health Forum article finding that this policy was associated with the higher Medicaid...

Overuse of health care, or providing services of low value or no value, is wasteful, potentially harmful to patients, and a contributor to high US health care costs. Jodi Segal, MD, of the Johns Hopkins University School of Medicine joins JAMA Health Forum Editor John Ayanian and Deputy Editor Melinda Buntin to discuss characteristics of health systems associated with overuse of health care servic...

Cost sharing is particularly burdensome for some Medicare beneficiaries, particularly those with incomes just above the poverty level, those with disabilities, or those who have multiple chronic health conditions. Jeanne Madden, PhD, of the Northeastern University School of Pharmacy, and Eric Roberts, PhD, of the University of Pittsburgh Graduate School of Public Health, speak with JAMA Health For...

There are many actors in the drug supply and distribution system, and little is known about the share of drug expenditures going to each, making it more difficult to rein in costs. JAMA Health Forum Associate Editor, Julie Donohue, PhD, and Deputy Editor, Melinda Buntin, PhD, speak with Neeraj Sood, PhD, lead author in a JAMA Health Forum study that unpacks the distribution of insulin expenditures...

State Medicaid programs are required to cover all drugs approved by the US Food & Drug Administration (FDA), including those that have received accelerated approval from the FDA to treat serious or life-threatening illnesses such as HIV or cancer. These drugs with accelerated approval may be beneficial based on surrogate end points such as changes in imaging or blood test results, but they have no...

We know that the pandemic caused millions of people to lose their jobs, and potentially their job-based insurance, and yet new survey data showed surprisingly small changes in uninsurance rates at the end of 2020. Kate Bundorf, PhD, from the Sanford School of Public Policy at Duke University and Jessica Banthin, PhD, of the Urban Institute talk to JAMA Health Forum Deputy Editor Melinda Buntin abo...

Firearms are the most common method of suicide in the US over the past decade. Primary care and mental health clinicians frequently interact with individuals at risk for suicide, but clinicians are often unaware of whether these patients have access to firearms. Julie Richards, PhD, from the Kaiser Permanente Washington Health Research Institute talks to JAMA Health Forum Editor John Ayanian and D...

The COVID-19 pandemic has had far-reaching effects on the use of health care services. Dr Nora Becker of the University of Michigan talks about her research on reductions in the use of women's preventive health services, and JAMA Health Forum Editors Dr John Ayanian and Dr Melinda Buntin discuss other JAMA Health Forum pieces on the effects of state "reopenings" on COVID-19 hospitalizations and de...

Participating in value-based incentive programs imposes financial and time costs on physician practices.  Dhruv Khullar of Weill Cornell Medical College and Jason Hockenberry of Yale School of Public Health discuss these burdens, the challenge of quality measurement, and ways increase the "value" of value-based payment programs like Medicare's Merit-based Incentive Payment System (MIPS).  Related...

A portfolio approach to health care payment reform, where a set number of alternative payment models are selected for testing because they work together to reduce waste, could be a more efficient way to reduce costs and incentivize quality. Michael Chernew, PhD, of Harvard University explains the idea in a conversation with JAMA Health Forum editors John Ayanian, MD, MPP and Melinda Buntin, PhD. R...

JAMA Health Forum is a peer-reviewed, open access, online journal, focused on health policy, health care systems, and population health.  Our podcast each month presents highlights of new content from the journal, including timely interviews with authors of research studies and commentaries.  Follow us on jamahealthforum.com and jamanetworkaudio.com .